Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 | 241877473 | intron variant | C/T | snv | 0.54 |
|
0.800 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 1 | 241870961 | intron variant | A/G | snv | 2.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||||
|
1 | 241865502 | intron variant | T/C | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1 | 241854524 | intron variant | C/G | snv | 0.62 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.882 | 0.040 | 1 | 241860596 | missense variant | A/G;T | snv | 2.4E-02; 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.040 | 1 | 241860596 | missense variant | A/G;T | snv | 2.4E-02; 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.040 | 1 | 241860596 | missense variant | A/G;T | snv | 2.4E-02; 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 1 | 241870961 | intron variant | A/G | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 1 | 241870961 | intron variant | A/G | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2012 | 2016 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2012 | 2016 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 0.667 | 3 | 2008 | 2014 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 0.667 | 3 | 2008 | 2014 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 0.667 | 3 | 2008 | 2014 | ||||||
|
0.752 | 0.240 | 1 | 241889740 | 3 prime UTR variant | A/G | snv | 0.72 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2008 | 2009 | |||||||
|
0.752 | 0.240 | 1 | 241889740 | 3 prime UTR variant | A/G | snv | 0.72 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2008 | 2009 | |||||||
|
0.752 | 0.240 | 1 | 241889740 | 3 prime UTR variant | A/G | snv | 0.72 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2008 | 2009 | |||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.708 | 0.280 | 1 | 241878999 | missense variant | G/A | snv | 0.36 | 0.40 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 |